News and Trends 26 Aug 2022 Beyond Biotech podcast 11: Ilya Pharma, IRB Barcelona, Krystal Biotech, Phase Genomics …to start a clinical trial for cystic fibrosis after the United States Food and Drug Administration (FDA) accepted its investigational new drug (IND) application. The gene therapy company will be… August 26, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 10 Nov 2022 Parthenon and ImaginAb enter into license and supply agreement for anti-cancer therapies …its investigational CD8 ImmunoPET technology to Parthenon Therapeutics for use in the clinical development of PRTH-101 at clinical trial sites across the United States. Initially, Parthenon Therapeutics will investigate CD8… November 10, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 23 Mar 2017 A Cheaper Heat-Stable Vaccine Could Prevent Child Deaths in Africa …III trial that has ever been done in Niger, and it will be probably be the first vaccine that is pre-qualified [for United Nations subsidies] out of the cold chain,”… March 23, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jul 2020 Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy …closing of the Series C round, Freeline also stated that “it expects to consider additional capital raising options this year, which could include an initial public offering in the United… July 2, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 5 Oct 2022 FDA fast tracks Immutep non-small cell lung cancer candidate Immutep Limited says the United States Food and Drug Administration (FDA) has granted fast track designation to eftilagimod alpha (efti or IMP321) in combination with pembrolizumab for the treatment of… October 5, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jun 2025 Pushing biotech forward in France: 18 companies to know about …United States. To support this, Polygon secured €7.5 million ($8.6 million) in seed funding and has been recognized by programs such as Innov’Up Leader PIA. Sensorion Founded: 2009 Headquarters: Montpellier,… June 10, 2025 - 16 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 10 Nov 2022 SOTIO reveal potential treatment for adults with solid tumors at SITC meeting …total of approximately 320 patients with a maximum of 50 to 57 per indication in Europe and the United States. SOTIO entered into a clinical trial collaboration and supply agreement… November 10, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 20 Apr 2017 Goodbye Glybera! The World’s First Gene Therapy will be Withdrawn …not go for the renewal of its marketing authorization for Glybera in Europe, which is set to expire in October this year. Since Glybera missed approval in the United States,… April 20, 2017 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 27 Jun 2025 Psychedelics sans side effects: neuroplastogens gain ground …Convention last week, was recently issued a ‘Notice of Allowance’ for its new class of neuroplastogens called aminated tryptamine derivatives by the United States Patent and Trademark Office (USPTO). This… June 27, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
More News! 7 Nov 2022 Sensorion granted rare pediatric disease designation by FDA for lead therapy gene …congenital hearing loss, around 20,000 people are affected in the United States and in Europe. Sensorion has progressed preclinical and clinical development plans for OTOF-GT and is on track to… November 7, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 12 Jul 2017 Genomic Testing in Oncology: From Single Genes to Whole Genomes …for Molecular Pathology v. Myriad Genetics“ challenged the validity of gene patents in the United States, specifically patents owned by Myriad Genetics that covered human DNA sequences, including BRCA. Since… July 12, 2017 - 5 minutesmins - By Timothé Cynober Share WhatsApp Twitter Linkedin Email
In Depth 31 Oct 2025 Spooky science: lab-grown breakthroughs or nightmares? …the 1980s, it really picked up in the past decade, and companies like Maryland-based United Therapeutics Corporation have printed a human lung scaffold with 4,000 kilometers of capillaries and 200… October 31, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email